surpass trial tirzepatide (Mounjaro) received a priority review from @US_FDA for #T2D reflecting the unprecedented reductions in A1c and #weightloss across the P3 clinical program SURPASS-5: Tirzepatide lowers HbA1c in
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4



00243-1/asset/3e6344be-cfd8-4182-b471-5c447dcc78dd/main.assets/gr1_lrg.jpg)


.png?w=1280&max-h=720&fit=crop&auto=format)





















